PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Antonino Glaviano; Aaron Song Chuan Foo; Hiu Yan Lam; Kenneth Chun-Yong Yap; William Jacot; Robert H. Jones; Huiyan Eng; Madhumathy G Nair; Pooyan Makvandi; Birgit Geoerger; Matthew H. Kulke; Richard D. Baird; Jyothi S. Prabhu; Daniela Carbone; Camilla Pecoraro; Daniel Boon Loong Teh; Gautam Sethi; Vincenzo Cavalieri; Kevin Lin; Nathalie Javidi‐Sharifi; Eneda Toska; Matthew S. Davids; Jennifer R. Brown; Patrizia Diana; Justin Stebbing; David A. Fruman; Alan Prem Kumar

doi:10.1186/s12943-023-01827-6

Keywords

PI3K/AKT/mTOR pathwayBiologySignal transductionProtein kinase BCancer researchRPTORCancerTransduction (biophysics)BioinformaticsComputational biologyCell biologyGeneticsBiochemistry

Affiliated Institutions

Related Publications

Targeting PI3K/Akt signal transduction for cancer therapy

Yan He , Miao Sun , Guo Geng Zhang +4 more

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various cellular processes and is aberrantly activated in cancers, contributing to the occurrence an...

2021 Signal Transduction and Targeted Therapy 1437 citations

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry , Sandra Pavey , Christine A. Pratilas +26 more

Abstract Selumetinib (AZD6244, ARRY-142886) is a selective, non–ATP-competitive inhibitor of mitogen-activated protein/extracellular signal–regulated kinase kinase (MEK)-1/2. Th...

2010 Cancer Research 259 citations

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

Gregory J. Brunn , Christine C. Hudson , Aleksandar Sekulić +5 more

The immunosuppressant rapamycin interferes with G 1 -phase progression in lymphoid and other cell types by inhibiting the function of the mammalian target of rapamycin (mTOR). m...

1997 Science 956 citations

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Jing Yang , Ji Nie , Xuelei Ma +3 more

Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master ...

2019 Molecular Cancer 1491 citations

The Phosphoinositide 3-Kinase Pathway

Lewis C. Cantley

Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components. The role of ph...

2002 Science 5531 citations

Publication Info

Year: 2023
Type: review
Volume: 22
Issue: 1
Pages: 138-138
Citations: 1396
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1396

OpenAlex

Cite This

APA Style

                            
                                
                                    Antonino Glaviano, 
                                
                                    Aaron Song Chuan Foo, 
                                
                                    Hiu Yan Lam
                                
                                et al.
                            
                            (2023). 
                            PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. 
                            Molecular Cancer
                            , 22
                            (1)
                            , 138-138.
                            https://doi.org/10.1186/s12943-023-01827-6
                        

Identifiers

DOI: 10.1186/s12943-023-01827-6